San Jose, CA, United States of America

Charles Garrett Miyada

USPTO Granted Patents = 24 

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 1,455(Granted Patents)


Location History:

  • Sunnyvale, CA (US) (2006)
  • Mountain View, CA (US) (1993 - 2008)
  • San Jose, CA (US) (2000 - 2020)

Company Filing History:


Years Active: 1993-2020

Loading Chart...
24 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Charles Garrett Miyada - Pioneering Methylation Analysis for Genomic Discoveries

Introduction:

Charles Garrett Miyada, a prominent inventor hailing from San Jose, California, has made significant contributions to the field of genomic research. With an impressive portfolio of 24 patents under his name, Miyada has revolutionized the study of methylation using nucleic acid arrays.

Latest Patents:

Miyada's groundbreaking patents include the "Analysis of Methylation Using Nucleic Acid Arrays," which introduce arrays for genome-wide analysis of methylation. These arrays consist of probes complementary to identified CpG islands in the human, mouse, and rat genomes, enabling the detection of methylation within samples from these genomes.

Career Highlights:

Currently affiliated with Syntex (U.S.A.) Inc., Miyada continues to push the boundaries of scientific innovation in the realm of genomic research. His keen insights and dedication have cemented his reputation as a trailblazer in the field.

Collaborations:

Throughout his career, Miyada has collaborated with esteemed colleagues such as Maureen T. Cronin and Mark S. Chee. Together, they have collectively advanced the frontiers of genomic analysis and played a pivotal role in shaping the future of the industry.

Conclusion:

In conclusion, Charles Garrett Miyada stands as a testament to the power of innovation and perseverance in the face of complex scientific challenges. His inventive spirit and relentless pursuit of excellence have left an indelible mark on the field of genomic research, inspiring future generations of inventors to continue pushing the boundaries of what is possible in the exciting world of molecular biology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…